M2 Archive: Preview
You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.
ABL Diagnostics and Laborama officially appointed to offer NGS genotyping solutions to the National Laboratory for Public Health (NLPH) in Lithuania.
Woippy (France) - ABL Diagnostics (FR001400AHX6 - ABLD, the "Company"), a Euronext-listed company that develops molecular biology assays and software for microbiology laboratories is pleased to announce today the official appointment of the company and its exclusive distributor, Laborama...
If you want to view the full text of this story, you must first purchase archive credits. Return to Archives
New Search